Answer
Smoking induces CYP1A2, increasing mexiletine hydrochloride clearance 1.3–1.7-fold and reducing its elimination half-life and exposure; the dose may need increasing when smoking starts and decreasing when smoking stops.
Sources for this answer
- Namuscla 167 mg hard capsulesLupin Healthcare (UK) Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 3Document updated
Sources checked